Ji Wang
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
Papers in
- Epidemiology 18
- Respiratory viral infections research 8
- Influenza Virus Research Studies 4
-
- Viral gastroenteritis research and epidemiology 9
- SARS-CoV-2 and COVID-19 Research 5
- Co-authors
- Mei X. Wu (8 shared papers)Xi Xie (15 shared papers)Hui‐Jiuan Chen (10 shared papers)Yang Yu (2 shared papers)Lu Lu (3 shared papers)Shibo Jiang (3 shared papers)Peiyu Li (3 shared papers)Min Lu (1 shared paper)
- Journals
- Frontiers in Microbiology (3 papers)Journal of Medical Virology (3 papers)Nature Communications (3 papers)PLoS ONE (2 papers)Journal of Advanced Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ji Wang
54 papers receiving 1.6k citations
Ji Wang's Hit Papers
Peers
Comparison fields: 5 of 118
- Pharmaceutical Science 120
- Infectious Diseases 315
- Immunology 355
- Epidemiology 238
- Biomedical Engineering 323
Countries citing papers authored by Ji Wang
This map shows the geographic impact of Ji Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Wang more than expected).
Fields of papers citing papers by Ji Wang
This network shows the impact of papers produced by Ji Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Wang. The network helps show where Ji Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ji Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 247 | |
| 2 | 2018 | 202 | |
| 3 | 2022 | 125 | |
| 4 | 2022 | 107 | |
| 5 | 2022 | 97 | |
| 6 | 2022 | 82 | |
| 7 | 2015 | 65 | |
| 8 | 2022 | 61 | |
| 9 | 2015 | 51 | |
| 10 | 2024 | 46 | |
| 11 | 2018 | 37 | |
| 12 | Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures Hit paper breakdown → | 2025 | 36 |
| 13 | 2024 | 31 | |
| 14 | 2018 | 27 | |
| 15 | 2018 | 26 | |
| 16 | 2013 | 25 | |
| 17 | 2014 | 22 | |
| 18 | 2022 | 21 | |
| 19 | 2015 | 21 | |
| 20 | 2013 | 18 |
About Ji Wang
Ji Wang is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Biomedical Engineering and Cardiology and Cardiovascular Medicine, having authored 56 papers that have together received 1.6k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (9 papers), Respiratory viral infections research (8 papers), Viral Infections and Immunology Research (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Microfluidic and Bio-sensing Technologies (4 papers), Influenza Virus Research Studies (4 papers), Advancements in Transdermal Drug Delivery (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Pharmaceutical Science (120 citations), Infectious Diseases (315 citations), Immunology (355 citations), Epidemiology (238 citations) and Biomedical Engineering (323 citations). Ji Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Mei X. Wu, Xi Xie, Hui‐Jiuan Chen, Yang Yu, Lu Lu, Shibo Jiang, Peiyu Li, Min Lu, Hongye Jiang and YuHong Fu. Their work appears in journals such as Frontiers in Microbiology, Journal of Medical Virology, Nature Communications, PLoS ONE and Journal of Advanced Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.